Document is current
Any future updates will be listed below
-
Authors
Hatano, Mai
Miyazaki, Tomoyuki
Ishiwata, Yoshinobu
Nakajima, Waki
Arisawa, Tetsu
Kuroki, Yoko
Kobayashi, Ayako
Takada, Yuuki
Ogawa, Matsuyoshi
Kawamura, Kazunori
Zhang, Ming-Rong
Higuchi, Makoto
Taguri, Masataka
Kimura, Yasuyuki
Takahashi, Takuya
-
Funding
Funding for this research was provided by:
Special Coordination Funds for Promoting Science and Technology
Japan Agency for Medical Research and Development (JP19lm0203007)
- License Information
-
More Information
Article History
Received: 6 July 2020
Accepted: 29 December 2020
First Online: 15 January 2021
Competing interests
: Takuya Takahashi and Tomoyuki Miyazaki are the inventors of a patent application for a novel compound that specifically binds to the AMPA receptor (WO 2017006931), including [<sup>11</sup>C]K-2. Takuya Takahashi, Tomoyuki Miyazaki and Tetsu Arisawa are the founders and also stockholders of AMPAMETRY, Inc., which holds the exclusive license to use [<sup>11</sup>C]K-2. No other potential conflicts of interest relevant to this article exist.
